English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Latest Press Releases
Thursday, January 4, 2024
STRATACACHE Partners With the National Retail Federation on New 'What's in Store for Retail Media Networks' Event
07:00 HKT/SGT
BLUETTI Unveils Its Newest Products at CES 2024
07:00 HKT/SGT
Kadena Launches #NewKadena, a Strategic Evolution of the Kadena Brand
00:00 HKT/SGT
Wednesday, January 3, 2024
冠科美博在中国完成复发或难治性急性髓细胞白血病uproleselan药物的三期临床桥接研究入组
20:10 HKT/SGT
冠科美博在中國完成復發或難治性急性髓細胞白血病uproleselan藥物的三期臨床橋接研究入組
20:09 HKT/SGT
Novationwire Brings Expertise to UAE, Debuting Dubai Headquarters Next January
10:00 HKT/SGT
Novationwire進駐阿聯酋,將於2024年一季度在迪拜設立辦事處
09:03 HKT/SGT
Novationwire进驻阿联酋,将于2024年一季度在迪拜设立办事处
09:02 HKT/SGT
Novationwire Brings Expertise to UAE, Debuting Dubai Headquarters Next January
09:00 HKT/SGT
Alexa Tsui Appointed Chief Operating Officer of G2Xchange
08:27 HKT/SGT
Tuesday, January 2, 2024
方正证券予碧瑶 (1397.HK)强烈推荐评级 目标价1.10港元 57%上升空间
18:18 HKT/SGT
方正證券予碧瑤 (1397.HK)強烈推薦評級 目標價1.10港元 57%上升空間
18:17 HKT/SGT
Founder Securities rates Baguio (1397.HK) as 'Strongly Recommended' with a HK$1.10 target price, indicating a 57% upside
18:16 HKT/SGT
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA
15:00 HKT/SGT
Bona Film Group invests in Hollywood blockbusters including "Avatar Franchise" via TSG Entertainment
14:30 HKT/SGT
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA
14:00 HKT/SGT
Trescon Lights Up 2023: A Year of Innovation and Growth
07:37 HKT/SGT
Monday, January 1, 2024
It's 2024. Can Technology Drive a New Nigerian Economy?
23:50 HKT/SGT
 ACN Search:
 
Viberse launches Tango: A playful way to meet new faces worldwide
 
Daily Newsletter
Browse Press Releases
Press Releases by Industry »
Press Releases by Language »
Multimedia Press Releases »
Events newsroom »
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575